| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |